These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9668253)

  • 41. Anti-acetylcholine receptor antibody synthesis by cultured lymphocytes in myasthenia gravis: thymic and peripheral blood cell interactions.
    Newsom-Davis J; Willcox N; Scadding G; Calder L; Vincent A
    Ann N Y Acad Sci; 1981; 377():393-402. PubMed ID: 6978662
    [No Abstract]   [Full Text] [Related]  

  • 42. Myasthenia gravis: acetylcholine receptor antibodies and beyond.
    Burde RM
    J Clin Neuroophthalmol; 1981 Mar; 1(1):63-6. PubMed ID: 6213647
    [No Abstract]   [Full Text] [Related]  

  • 43. T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients.
    Oshima M; Deitiker PR; Smith RG; Mosier D; Atassi MZ
    Autoimmunity; 2012 Mar; 45(2):153-60. PubMed ID: 21985279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis.
    Ostlie NS; Karachunski PI; Wang W; Monfardini C; Kronenberg M; Conti-Fine BM
    J Immunol; 2001 Apr; 166(8):4853-62. PubMed ID: 11290761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thymus, thymoma, and specific T cells in myasthenia gravis.
    Beeson D; Bond AP; Corlett L; Curnow SJ; Hill ME; Jacobson LW; MacLennan C; Meager A; Moody AM; Moss P; Nagvekar N; Newsom-Davis J; Pantic N; Roxanis I; Spack EG; Vincent A; Willcox N
    Ann N Y Acad Sci; 1998 May; 841():371-87. PubMed ID: 9668262
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunoregulatory CD8+ cells recognize antigen-activated CD4+ cells in myasthenia gravis patients and in healthy controls.
    Yuen MH; Protti MP; Diethelm-Okita B; Moiola L; Howard JF; Conti-Fine BM
    J Immunol; 1995 Feb; 154(3):1508-20. PubMed ID: 7529806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myasthenia gravis. T epitopes on the delta subunit of human muscle acetylcholine receptor.
    Protti MP; Manfredi AA; Wu XD; Moiola L; Howard JF; Conti-Tronconi BM
    J Immunol; 1991 Apr; 146(7):2253-61. PubMed ID: 1706391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Respective role of thymus and muscle in autoimmune myasthenia gravis.
    Moulian N; Wakkach A; Guyon T; Poëa S; Aïssaoui A; Levasseur P; Cohen-Kaminsky S; Berrih-Aknin S
    Ann N Y Acad Sci; 1998 May; 841():397-406. PubMed ID: 9668265
    [No Abstract]   [Full Text] [Related]  

  • 49. T cells in myasthenia gravis specific for embryonic acetylcholine receptor.
    Protti MP; Manfredi AA; Howard JF; Conti-Tronconi BM
    Neurology; 1991 Nov; 41(11):1809-14. PubMed ID: 1682852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
    Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
    Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
    Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
    J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T cells and cytokines in the pathogenesis of acquired myasthenia gravis.
    Milani M; Ostlie N; Wang W; Conti-Fine BM
    Ann N Y Acad Sci; 2003 Sep; 998():284-307. PubMed ID: 14592887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of experimental autoimmune myasthenia gravis by recombinant fragments of the human acetylcholine receptor.
    Souroujon MC; Barchan D; Fuchs S
    Ann N Y Acad Sci; 1998 May; 841():572-5. PubMed ID: 9668298
    [No Abstract]   [Full Text] [Related]  

  • 54. The thymus and myasthenia gravis.
    Ragheb S; Lisak RP
    Chest Surg Clin N Am; 2001 May; 11(2):311-27, x. PubMed ID: 11413758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epitope spreading to hidden cytoplasmic regions of the acetylcholine receptor in experimental autoimmune myasthenia gravis.
    Feferman T; Im SH; Fuchs S; Souroujon MC
    Ann N Y Acad Sci; 2003 Sep; 998():388-90. PubMed ID: 14592902
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of myasthenia gravis with anti-CD4 antibody: improvement correlates to decreased T-cell autoreactivity.
    Ahlberg R; Yi Q; Pirskanen R; Matell G; Swerup C; Rieber EP; Riethmüller G; Holm G; Lefvert AK
    Neurology; 1994 Sep; 44(9):1732-7. PubMed ID: 7936306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acetylcholine receptor epitope in proteins of myasthenia gravis-associated thymomas and non-thymic tissues.
    Marx A; O'Connor R; Tzartos S; Kalies I; Kirchner T; Müller-Hermelink HK
    Thymus; 1989; 14(1-3):171-8. PubMed ID: 2482999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular anatomy of an autoantigen: T and B epitopes on the nicotinic acetylcholine receptor in myasthenia gravis.
    Manfredi AA; Protti MP; Bellone M; Moiola L; Conti-Tronconi BM
    J Lab Clin Med; 1992 Jul; 120(1):13-21. PubMed ID: 1377215
    [No Abstract]   [Full Text] [Related]  

  • 59. Prospects for specific immunotherapy in myasthenia gravis.
    Steinman L; Mantegazza R
    FASEB J; 1990 Jul; 4(10):2726-31. PubMed ID: 2197152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: autoantibody mediated up-regulation of the response of acetylcholine receptor-specific T lymphocytes.
    Zhang Y; Tzartos S
    Immunology; 1992 Dec; 77(4):571-6. PubMed ID: 1283599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.